Spok Holdings, Inc. (SPOK)
NASDAQ: SPOK · Real-Time Price · USD
13.02
-0.01 (-0.08%)
At close: Dec 5, 2025, 4:00 PM EST
13.20
+0.18 (1.38%)
After-hours: Dec 5, 2025, 6:05 PM EST
Spok Holdings Market Cap
Spok Holdings has a market cap or net worth of $268.19 million as of December 5, 2025. Its market cap has decreased by -19.15% in one year.
Market Cap
268.19M
Enterprise Value
254.17M
1-Year Change
-19.15%
Ranking
Category
Stock Price
$13.02
Market Cap Chart
Since December 31, 2004, Spok Holdings's market cap has decreased from $947.30M to $268.19M, a decrease of -71.69%. That is a compound annual growth rate of -5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 268.40M | -17.52% |
| Dec 31, 2024 | 325.40M | 5.21% |
| Dec 29, 2023 | 309.30M | 91.64% |
| Dec 30, 2022 | 161.40M | -11.22% |
| Dec 31, 2021 | 181.80M | -14.37% |
| Dec 31, 2020 | 212.30M | -7.94% |
| Dec 31, 2019 | 230.60M | -10.62% |
| Dec 31, 2018 | 258.00M | -17.49% |
| Dec 29, 2017 | 312.70M | -26.63% |
| Dec 30, 2016 | 426.20M | 10.79% |
| Dec 31, 2015 | 384.70M | 2.21% |
| Dec 31, 2014 | 376.40M | 21.73% |
| Dec 31, 2013 | 309.20M | 20.64% |
| Dec 31, 2012 | 256.30M | -16.41% |
| Dec 30, 2011 | 306.60M | -21.81% |
| Dec 31, 2010 | 392.10M | 57.47% |
| Dec 31, 2009 | 249.00M | -20.88% |
| Dec 31, 2008 | 314.70M | -19.41% |
| Dec 31, 2007 | 390.50M | -36.17% |
| Dec 29, 2006 | 611.80M | -19.06% |
| Dec 30, 2005 | 755.90M | -20.20% |
| Dec 31, 2004 | 947.30M | - |
| Dec 31, 2004 | 947.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |